Blood Diagnostics

Selected news for the healthcare topic - Blood Diagnostics, collected since 11/2017. Recent stories appear in Phys Org and mysticmedusa.com. This healthcare topic shares news with T2 Biosystems, Genalyte, Kevin Lo and many others.

Please provide a valid email address.
Shares Healthcare News With (link):
Companies

Selected Headlines

Date Headline (link) Source Relevant Snippet
3/29/2021 International team uncovers mystery behind 'coffee ring' formation Phys Org by Monash University A new study has discovered the mystery behind 'coffee rings' and how it could advance research in blood diagnostics . Credit: Monash UniversityAn international research team, led by Monash University, has discovered for the first time the mystery behind the formation of 'coffee rings' by examining the contact angle of droplets onto a surface, and how they dry.The research collaboration involving Monash University and Cambridge University ...
3/15/2021 The (Astrological) Future Of Work mysticmedusa.com People say that the future of work is decentralized, but ‘people’ also said that in 2021 we’d fly our car to work. Robots would make quality leisure time society’s biggest challenge, and you’d be able to do quick pinprick blood diagnostics in the bathroom while your prickly pear enzyme face mask is activated. Between propaganda, confirmation bias, and the bureaucratic jargon that George ‘1984’ Orwell ...
3/11/2021 Israel's Sight Diagnostics’ Sight OLO Deployed at Oxford University's John Radcliffe Hospital algemeiner.com Israeli company Sight Diagnostic’s Sight OLO blood diagnostics device. Photo: Sight Diagnostics via Facebook.CTech – Sight Diagnostics, an Israeli company that delivers lab-grade Full Blood Count (FBC) results in just a few minutes, has deployed its Sight OLO solution at the John Radcliffe Hospital, part of Oxford University Hospitals NHS Foundation. The deployment means that patients who attend the emergency departments have access to quick FBC testing ...
3/5/2021 Veterinary X-ray Market Growing at a CAGR of 6.4% – Segmentation, Geographical Analysis & Major Key Players dailygram.com ... a partnership with Pathway Vet Alliance (US). Under the terms of this agreement, Pathway plans to align its internal diagnostic portfolio with Heska, which can provide in-house operational services like point-of-care blood diagnostics , digital imaging, and allergy testing. In 2018, Carestream Health signed a service partnership agreement with Med Imaging Healthcare, a Diagnostic Imaging equipment maintenance company. The partnership was aimed at providing wider maintenance coverage and ...
3/5/2021 Veterinary X-ray Market Growing at a CAGR of 6.4% – Growth and key Players Analysis and Forecast Tumblr ... a partnership with Pathway Vet Alliance (US). Under the terms of this agreement, Pathway plans to align its internal diagnostic portfolio with Heska, which can provide in-house operational services like point-of-care blood diagnostics , digital imaging, and allergy testing. In 2018, Carestream Health signed a service partnership agreement with Med Imaging Healthcare, a Diagnostic Imaging equipment maintenance company. The partnership was aimed at providing wider maintenance coverage and ...
3/4/2021 Veterinary X-ray Market Growing at a CAGR of 6.4% – Growth in Companion Animal Population emailwire.com ... a partnership with Pathway Vet Alliance (US). Under the terms of this agreement, Pathway plans to align its internal diagnostic portfolio with Heska, which can provide in-house operational services like point-of-care blood diagnostics , digital imaging, and allergy testing. In 2018, Carestream Health signed a service partnership agreement with Med Imaging Healthcare, a Diagnostic Imaging equipment maintenance company. The partnership was aimed at providing wider maintenance coverage and ...
12/9/2020 Sight Diagnostics® Expands to the Gulf Region through a Distribution Partnership with Phoenix Capital Business Wire ... settings. As such, there is an increasing demand for modern POC diagnostics in the Middle East and Africa, with the market projected to reach $2.85 billion by 2024 .Sight OLO enables fast, accurate, convenient blood diagnostics by delivering CBC results in minutes right at the point-of-care . About the size of a toaster oven, OLO is small, compact, and light-weight, allowing for quick, simple set-up wherever it ...
12/2/2020 [Sight Diagnostics in MedCity News] MedCity Pivot Podcast: Sight Diagnostic's exec talks about using computer vision in blood diagnostics ourcrowd.com JoinSelect Page [Sight Diagnostics in MedCity News] MedCity Pivot Podcast: Sight Diagnostic’s exec talks about using computer vision in blood diagnosticsDec 2, 2020 News Center Share: In this episode of the MedCity Pivot podcast, Daniel Levner, co-founder and chairman of the scientific advisory board at Sight Diagnostics, explains how computer vision is changing blood diagnostics ...
11/30/2020 MedCity Pivot Podcast: Sight Diagnostic's exec talks about using computer vision in blood diagnostics MedCity News Due to the infamy of Theranos , even those not involved in the world of healthcare, know something about blood diagnostics and the effort to make it less burdensome.While the Theranos saga has burned investors, revealed a troubled entrepreneur and perhaps even created some hurdles for women entrepreneurs, other startups with similar aims haven’t given up their ambition to transform the world of complete blood count testing and other ...
11/2/2020 COVAXX and Maersk Enter Partnership to Supply COVID-19 Vaccines Globally logistics-manager.com ... arms. The investigational vaccine is designed to mimic natural biology and preclinical studies have shown high immunogenicity and levels of neutralizing titers against SARS-CoV-2. The technology platform has been successful in commercializing blood diagnostics as well as safe and effective vaccines for infectious disease in animal health and has been tested in numerous clinical trials for other indications to date.COVAXX is currently conducting Phase 1 clinical trials ...
10/28/2020 COVAXX, a U.S. company developing a multitope synthetic pept hellenicshippingnews.com ... arms. The investigational vaccine is designed to mimic natural biology and preclinical studies have shown high immunogenicity and levels of neutralizing titers against SARS-CoV-2. The technology platform has been successful in commercializing blood diagnostics as well as safe and effective vaccines for infectious disease in animal health and has been tested in numerous clinical trials for other indications to date.COVAXX is currently conducting Phase 1 clinical trials ...
10/28/2020 Maersk and COVAXX partner to supply global COVID-19 vaccines supplychaindigital.com ... The investigational vaccine has been manufactured to replicate natural biology and preclinical studies have outlined high immunogenicity and levels of neutralising titers against SARS-COV-2. The technology platform has been successful in commercialising blood diagnostics as well as safe and effective vaccines for infectious disease in animal health and has been tested in a number of clinical trials for other indications to date.The organisation is currently conducting Phase ...
10/26/2020 COVAXX and Maersk partner for COVID-19 vaccines maritimeprofessionals.net ... arms. The investigational vaccine is designed to mimic natural biology and preclinical studies have shown high immunogenicity and levels of neutralizing titers against SARS-CoV-2. The technology platform has been successful in commercializing blood diagnostics as well as safe and effective vaccines for infectious disease in animal health and has been tested in numerous clinical trials for other indications to date.COVAXX is currently conducting Phase 1 clinical trials of ...
10/26/2020 COVAXX and Maersk enter partnership to supply COVID-19 vaccines globally ajot.com ... arms. The investigational vaccine is designed to mimic natural biology and preclinical studies have shown high immunogenicity and levels of neutralizing titers against SARS-CoV-2. The technology platform has been successful in commercializing blood diagnostics as well as safe and effective vaccines for infectious disease in animal health and has been tested in numerous clinical trials for other indications to date.COVAXX is currently conducting Phase 1 clinical trials ...
9/20/2020 Tamanaha_Takashi shared "森友問題 自殺職員の妻が訴え「菅さん逃げないで」|テレ朝news" blogspot.com ... achieve Unicorn status Research from New York Data Analytics firm CB Insights revealed the Arab world has just one single Unicorn Read more at Twitter DrEddyClinic 🇩🇪 and 1 other shared dreddymd.com Dark field blood diagnostics Dark field blood diagnostics is a Method of Professor Dr. Guenther Enderlein (1872-1968), that primarily a biologist ... Read more at Twitter DrEddyClinic 🇩🇪 and 1 other shared dreddymd.com 10 Best Herbs for Boosting Female ...
9/11/2020 Sight Diagnostics Gets $71 Million in Series D Funding healthcareweekly.com Shopping for Healthcare In a confirmation of its standing and potential in the blood diagnostics industry and its new flagship blood analysis product, Sight Diagnostics the company that developed and manufactured the first FDA-approved finger stick Complete Blood Count analyzer has raised $71 million dollars in its series D round of funding. Sight Diagnostics has become a market leader by developing an exciting blood diagnostics device that cuts the ...
9/9/2020 COVAXX Synthetic Multitope Vaccine Selected for Human Trials in Brazil by Dasa, the Largest Diagnostic Company, and Mafra the Leading Private Vaccine Distributor PR Newswire ... arms. UB-612 is designed to mimic natural biology and preclinical studies have shown very high immunogenicity and levels of neutralizing titers against SARS-CoV-2. The technology platform has been successful in commercializing blood diagnostics as well as safe and effective vaccines for infectious disease in animal health and has been tested in numerous clinical trials for other indications to date. "This donation is aligned with other efforts from ...
8/6/2020 PRESS RELEASE: Sight Diagnostics Raises $71M To Accelerate Global Expansion of itsFDA 510(k) Cleared, CE Marked Finger-prick Blood Analyzer ourcrowd.com ... vision to analyze blood is a significant leap forward from the current alternative in healthcare,” said Chase Koch, President of Koch Disruptive Technologies. “Not only is the company bringing truly innovative solutions to the blood diagnostics industry, it is also driving a vision to decentralize information and increase consumer access in healthcare markets across the world.” Founded in 2011, Sight Diagnostics aims to transform blood testing through its flagship Sight ...
8/5/2020 Sight Diagnostics raises $71M Series D for its blood analyzer TechCrunch ... gather the data to detect anomalies that may indicate the severity of some of the aspects of the disease. “We just kind of scratched the surface of the ability of AI to help with blood diagnostics ,” said Pollak. “Specifically now, there’s so much value around COVID in decentralizing diagnostics and blood tests. Think keeping people — COVID-negative or -positive — outside of hospitals to reduce the busyness of hospitals and reduce ...
8/5/2020 Tabletop blood tester Sight Diagnostics raises $71M to expand commercial reach FierceBiotech ... vision to analyze blood is a significant leap forward from the current alternative in healthcare,” said Chase Koch, president of Koch Disruptive Technologies. “Not only is the company bringing truly innovative solutions to the blood diagnostics industry, it is also driving a vision to decentralize information and increase consumer access in healthcare markets across the world.” RELATED: Tabletop blood count developer Sight raises $27.8M in series C round The cartridge ...